DVAX Competitors & Alternatives

Compare Dynavax Technologies Corporation with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

DVAX

Main Stock
$15.50
Tradestie Score
55
Market Cap
$1.21B
Revenue Growth
0.2%
Analyst Upside
+41.9%

Top Competitors

46 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
ANIP ANI Pharmaceuticals, Inc.
$86.03
$2.01B 21.2 64 Compare
LQDA Liquidia Corporation Common Stock
$78.93
$1.90B 466.6 55 Compare
TLRY Tilray Brands, Inc. Common Stock
$4.62
$1.84B - 61 Compare
HROW Harrow, Inc. Common Stock
$42.74
$1.79B - 62 Compare
PAHC Phibro Animal Health Corporation Class A
$33.26
$1.65B 13.8 54 Compare
BCRX BioCryst Pharmaceuticals Inc
$9.84
$1.55B - 56 Compare
AMLX Amylyx Pharmaceuticals, Inc. Common Stock
$18.27
$1.49B - 59 Compare
AVDL Avadel Pharmaceuticals plc Ordinary Share
$21.64
$1.46B - 62 Compare
EVO Evotec SE American Depositary Shares
$2.90
$1.34B - 56 Compare
XERS Xeris Biopharma Holdings, Inc. Common Stock
$8.28
$1.29B 114.3 58 Compare

Data updated: Jul 04, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

46 stocks in this industry